Tags

Type your tag names separated by a space and hit enter

Prevention and treatment of COVID-19-associated hypercoagulability: Recommendations of the Algerian society of transfusion and hemobiology.
Transfus Clin Biol. 2020 Nov; 27(4):203-206.TC

Abstract

Since December 2019, an outbreak of coronavirus disease 2019 (COVID-19) in Wuhan, China, has spread throughout the world. Coagulation dysfunction is one of the major causes of death in patients with severe COVID-19. Several recent observations in Algeria and elsewhere maintain that a pulmonary embolism is frequent in patients with COVID-19 with a high incidence in intensive care. In addition, other studies have shown that many deceased patients have diagnostic criteria for disseminated intravascular coagulation (DIC) set by the International society of hemostasis and thrombosis (ISTH). The office of the Algerian society of transfusion and hemobiology composed of hemostasis and blood transfusion experts from Algerian hospitals on the epidemic front line have established a consensus on the issue through 4 axes: Indication of thromboprophylaxis, monitoring of hemostasis, indications of transfusion in the event of disseminated intravascular coagulation (DIC) and anticoagulant treatment after discharge.

Authors+Show Affiliations

Service d'hémobiologie et banque de sang, EHU d'Oran, Oran, Algeria. Electronic address: chekkal.mohamed@univ-oran1.dz.Service d'hémobiologie et banque de sang, EHU d'Oran, Oran, Algeria.Centre d'hémobiologie et transfusion sanguine, CHU Mustapha-Bacha, Alger, Algeria.Centre d'hémobiologie et transfusion sanguine, CHU Mustapha-Bacha, Alger, Algeria.Service d'hémobiologie et banque de sang, CHU d'Annaba, Annaba, Algeria.Centre d'hémobiologie et transfusion sanguine, CHU Mustapha-Bacha, Alger, Algeria.Centre d'hémobiologie et transfusion sanguine, CHU Bab-El-Oued, Alger, Algeria.

Pub Type(s)

Journal Article
Practice Guideline

Language

eng

PubMed ID

33022374

Citation

Chekkal, M, et al. "Prevention and Treatment of COVID-19-associated Hypercoagulability: Recommendations of the Algerian Society of Transfusion and Hemobiology." Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine, vol. 27, no. 4, 2020, pp. 203-206.
Chekkal M, Deba T, Hadjali S, et al. Prevention and treatment of COVID-19-associated hypercoagulability: Recommendations of the Algerian society of transfusion and hemobiology. Transfus Clin Biol. 2020;27(4):203-206.
Chekkal, M., Deba, T., Hadjali, S., Lamara, H., Oulaa, H., Zouai, K., & Hariti, G. (2020). Prevention and treatment of COVID-19-associated hypercoagulability: Recommendations of the Algerian society of transfusion and hemobiology. Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine, 27(4), 203-206. https://doi.org/10.1016/j.tracli.2020.09.004
Chekkal M, et al. Prevention and Treatment of COVID-19-associated Hypercoagulability: Recommendations of the Algerian Society of Transfusion and Hemobiology. Transfus Clin Biol. 2020;27(4):203-206. PubMed PMID: 33022374.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Prevention and treatment of COVID-19-associated hypercoagulability: Recommendations of the Algerian society of transfusion and hemobiology. AU - Chekkal,M, AU - Deba,T, AU - Hadjali,S, AU - Lamara,H, AU - Oulaa,H, AU - Zouai,K, AU - Hariti,G, Y1 - 2020/10/03/ PY - 2020/05/29/received PY - 2020/09/23/revised PY - 2020/09/24/accepted PY - 2020/10/7/pubmed PY - 2020/11/20/medline PY - 2020/10/6/entrez KW - Anticoagulants KW - CIVD KW - COVID-19 KW - DIC KW - Hypercoagulability KW - Hypercoagulabilité KW - Transfusion SP - 203 EP - 206 JF - Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine JO - Transfus Clin Biol VL - 27 IS - 4 N2 - Since December 2019, an outbreak of coronavirus disease 2019 (COVID-19) in Wuhan, China, has spread throughout the world. Coagulation dysfunction is one of the major causes of death in patients with severe COVID-19. Several recent observations in Algeria and elsewhere maintain that a pulmonary embolism is frequent in patients with COVID-19 with a high incidence in intensive care. In addition, other studies have shown that many deceased patients have diagnostic criteria for disseminated intravascular coagulation (DIC) set by the International society of hemostasis and thrombosis (ISTH). The office of the Algerian society of transfusion and hemobiology composed of hemostasis and blood transfusion experts from Algerian hospitals on the epidemic front line have established a consensus on the issue through 4 axes: Indication of thromboprophylaxis, monitoring of hemostasis, indications of transfusion in the event of disseminated intravascular coagulation (DIC) and anticoagulant treatment after discharge. SN - 1953-8022 UR - https://www.unboundmedicine.com/medline/citation/33022374/Prevention_and_treatment_of_COVID_19_associated_hypercoagulability:_Recommendations_of_the_Algerian_society_of_transfusion_and_hemobiology_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1246-7820(20)30119-1 DB - PRIME DP - Unbound Medicine ER -